Immunic (IMUX) Competitor Comparison
We are evaluating the key criteria listed to compare Immunic (IMUX) against its competitors in the Biotechnology industry.
Market Capitalization
251 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
199 / 337Free Cashflow
189 / 352Quick Ratio
245 / 357Earnings per Share
191 / 359Dividend yield
0 / 6Total Cash
249 / 358Performance 3 years
323 / 368Performance 5 years
283 / 368Performance 10 years
358 / 368Linearity 3 years
263 / 368Linearity 5 years
184 / 368Linearity 10 years
308 / 368Total Rank
153 / 368Dividend Rank
157 / 368Valuation Rank
71 / 368Piotroski Rank
288 / 368Muliplier Rank
74 / 368Muliplier Rank - IMUX ranking 74 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.